Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.7.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Revenues:        
Royalties $ 14,211 $ 9,754 $ 38,441 $ 24,144
Material sales 5,550 3,886 6,672 9,227
License fees, milestones and other revenues 8,234 5,881 12,151 15,798
Total revenues 27,995 19,521 57,264 49,169
Operating costs and expenses:        
Cost of sales [1] 903 720 1,244 1,675
Amortization of intangibles 2,706 2,681 5,420 5,206
Research and development 4,822 4,914 13,495 8,915
General and administrative 6,549 7,237 13,872 14,309
Total operating costs and expenses 14,980 15,552 34,031 30,105
Income from operations 13,015 3,969 23,233 19,064
Other (expense) income:        
Interest expense, net (2,860) (3,051) (5,803) (6,055)
Increase in contingent liabilities (825) (332) (966) (1,638)
Loss from Viking (1,248) (11,138) (2,330) (12,743)
Other income, net 218 501 359 892
Total other expense, net (4,715) (14,020) (8,740) (19,544)
Income before income taxes 8,300 (10,051) 14,493 (480)
Income tax (expense) benefit (2,242) 3,881 (3,356) 187
Income (loss) from operations 6,058 (6,170) 11,137 (293)
Gain on sale of Oncology Product Line before income taxes 0 0 0 1,139
Income tax expense on discontinued operations 0 0 0 (408)
Income from discontinued operations 0 0 0 731
Net income (loss) $ 6,058 $ (6,170) $ 11,137 $ 438
Basic earnings (loss) per share data        
Income (loss) from continuing operations (in usd per share) [2] $ 0.29 $ (0.30) $ 0.53 $ (0.01)
Income from discontinued operations (in usd per share) [2] 0.00 0.00 0.00 0.04
Net income (loss) (in usd per share) 0.29 [2] (0.30) [2] 0.53 [2] 0.02
Diluted earnings per share data (2)        
Income (loss) from continuing operations (in usd per share) [2] 0.26 (0.30) 0.48 (0.01)
Income from discontinued operations (in usd per share) [2] 0.00 0.00 0.00 0.04
Net income (loss) (in usd per share) $ 0.26 [2] $ (0.30) $ 0.48 $ 0.02
Shares used for computation (in thousands)        
Basic (in shares) 21,013,000 20,832,000 20,975,000 20,765,000
Diluted (in shares) 23,215,900 20,831,809 23,117,164 20,765,053
[1] Excludes amortization of intangibles.
[2] The sum of net income per share amounts may not equal the totals due to rounding.